trans-4-(4-hydroxycyclohexylamino)imidazo[1,2-a]quinoxaline-8-carboxamide

ID: ALA2420587

Chembl Id: CHEMBL2420587

PubChem CID: 72164072

Max Phase: Preclinical

Molecular Formula: C17H19N5O2

Molecular Weight: 325.37

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1

Standard InChI:  InChI=1S/C17H19N5O2/c18-15(24)10-1-6-13-14(9-10)22-8-7-19-17(22)16(21-13)20-11-2-4-12(23)5-3-11/h1,6-9,11-12,23H,2-5H2,(H2,18,24)(H,20,21)/t11-,12-

Standard InChI Key:  FESDXUDFRLHTQL-HAQNSBGRSA-N

Alternative Forms

1. Parent:

   

   ALA2420587

   4-[(4-Hydroxycyclohexyl)amino]imidazo[1,2-a]quinoxaline-8-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 325.37

Molecular Weight (Monoisotopic): 325.1539

AlogP: 1.70

#Rotatable Bonds: 3

Polar Surface Area: 105.54

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 3.49

CX LogP: 0.28

CX LogD: 0.28

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.68

Np Likeness Score: -1.17

References

1. Li B, Cociorva OM, Nomanbhoy T, Weissig H, Li Q, Nakamura K, Liyanage M, Zhang MC, Shih AY, Aban A, Hu Y, Cajica J, Pham L, Kozarich JW, Shreder KR..  (2013)  Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.,  23  (18): [PMID:23916259] [10.1016/j.bmcl.2013.06.087]

Source

Source(1):

• Scientific Literature